CLINICAL_TRIALS
trial_result
· 2026-03-30
Clinical Trial Update: Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma [Phase 2]
Summary
A Phase 2 dose-ranging trial of amlitelimab in adults with moderate-to-severe asthma has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2026-03-30